LLY  valuation analysis

Basics
Name: Eli Lilly and Company
Description: Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 28, 2022
Market cap: $292.78B (21st)
Sales(TTM): $29.32B (112th)
Earnings(TTM): $6.13B (74th)

Value
FFER: 4.02 (why)
Actual price: $307.01
FFEThis is Eli Lilly and Company's the estimated price. FFEs are the denominator of the FFER ratio.: $76.41
Quantile: LLY is very expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Sales / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Book / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Equity / Assets
Eli Lilly and Company
"Drug Manufacturers-General" industry